Cargando…

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation

Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ), and ATG-Fresenius (ATG-FRES), with respect to do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oostenbrink, Lisa V. E., Jol-van der Zijde, Cornelia M., Kielsen, Katrine, Jansen-Hoogendijk, Anja M., Ifversen, Marianne, Müller, Klaus G., Lankester, Arjan C., van Halteren, Astrid G. S., Bredius, Robbert G. M., Schilham, Marco W., van Tol, Maarten J. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414431/ https://www.ncbi.nlm.nih.gov/pubmed/30894854 http://dx.doi.org/10.3389/fimmu.2019.00315

Ejemplares similares

Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme
por: Wang, Lu, et al.
Publicado: (2023)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
por: Admiraal, Rick, et al.
Publicado: (2019)

Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome
por: Kammersgaard, Marte B., et al.
Publicado: (2019)

Anti-thymocyte globulin in haematology: Recent developments
por: Siddiqui, Salahuddin, et al.
Publicado: (2019)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
por: Baron, Frédéric, et al.
Publicado: (2020)

Emergency Response to Natural Disasters: The Experience of Fresenius Medical Care
por: Sawin, Dixie-Ann, et al.
Publicado: (2023)

Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin
por: Yang, Dan, et al.
Publicado: (2019)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin
por: Zazula, Roman, et al.
Publicado: (2007)

Rabbit anti‐thymocyte globulin for the prevention of acute rejection in kidney transplantation
por: Alloway, Rita R., et al.
Publicado: (2019)

Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
por: Suk Lee, Young, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2022)

An unusual presentation of a patient with severe hypogammaglobulinemia
por: Hoffman, Thijs W., et al.
Publicado: (2018)

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
por: Ingham, Anna Cäcilia, et al.
Publicado: (2021)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

An Anti-Human Thymocyte Globulin-Based Reduced-Intensity Conditioning Regimen Is Associated with a Higher Quality of Life and Lower Organ Toxicity without Affecting Lymphocyte Reconstitution
por: Yu, Zheng-Ping, et al.
Publicado: (2013)

Anti Thymocyte Globulin-Based Treatment for Acquired Bone Marrow Failure in Adults
por: Tjon, Jennifer M.-L., et al.
Publicado: (2021)

Anti‐thymocyte globulin‐mediated immunosenescent alterations of T cells in kidney transplant patients
por: Lee, Ga Hye, et al.
Publicado: (2022)

ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation
por: Sebti, Maria, et al.
Publicado: (2022)

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
por: Bank, Jonna R., et al.
Publicado: (2016)

Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry
por: Amrani, Mohsin El, et al.
Publicado: (2020)

RECONSTITUTION OF 7S MOLECULES FROM L AND H POLYPEPTIDE CHAINS OF ANTIBODIES AND γ-GLOBULINS
por: Olins, D. E., et al.
Publicado: (1964)

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
por: van der Maas, Nicolaas G., et al.
Publicado: (2019)

Anti-thymocyte globulin induced non-cardiogenic pulmonary edema during renal transplantation
por: Parikh, Beena K., et al.
Publicado: (2011)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
por: Ko, Eun Jeong, et al.
Publicado: (2019)

Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy
por: Kawarada, Yo, et al.
Publicado: (2023)

Characteristics of Intracranial Aneurysms in the Else Kröner-Fresenius Registry of Autosomal Dominant Polycystic Kidney Disease
por: Neumann, Hartmut P.H., et al.
Publicado: (2012)

A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation
por: Mullen, John C, et al.
Publicado: (2014)

Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction
por: Lichtenauer, Michael, et al.
Publicado: (2012)

Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic Malignancies
por: Li, Qingshan, et al.
Publicado: (2015)

Serum sickness following rabbit anti-thymocyte globulin for acute vascular renal allograft rejection
por: Teng, Jessie, et al.
Publicado: (2012)

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy
por: Tay, Rebecca Y, et al.
Publicado: (2017)

Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation
por: Lee, Jae Geun, et al.
Publicado: (2016)

Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
por: Meesters-Ensing, J.I., et al.
Publicado: (2022)

Anti-Thymocyte Globulin Induced Acute Lung Injury in a Case of Renal Allograft Recipient
por: Gupta, Nimish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p67chuj3e2ej8m8m9elfdbnapo